Kohei Otsubo Selected Research

Kohei Otsubo Research Topics

Disease

20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 01/2014
15	Neoplasms (Cancer) 05/2022 - 01/2011
6	Disease Progression 12/2023 - 01/2012
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2024 - 01/2018
4	Idiopathic Pulmonary Fibrosis 12/2023 - 01/2018
3	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2023 - 10/2015
3	Adenocarcinoma of Lung 01/2020 - 10/2015
2	Pneumonia (Pneumonitis) 07/2018 - 09/2017
2	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2012
1	Mediastinitis 03/2024
1	Fistula 03/2024
1	Lung Diseases (Lung Disease) 12/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Overweight 08/2021
1	Diabetes Mellitus 08/2021
1	COVID-19 08/2021
1	Meningeal Carcinomatosis 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Dysbiosis 01/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2020
1	Sarcoidosis (Schaumann Disease) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Pleural Effusion (Pleural Effusions) 07/2018
1	Lung Neoplasms (Lung Cancer) 07/2018
1	Hypotension (Low Blood Pressure) 09/2017
1	Anorexia 09/2017
1	Infections 10/2015
1	Dyspnea (Shortness of Breath) 10/2015

Drug/Important Bio-Agent (IBA)

7	Tyrosine Kinase InhibitorsIBA 01/2021 - 09/2017
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2017
4	Immune Checkpoint InhibitorsIBA 01/2020 - 07/2018
3	PlatinumIBA 12/2018 - 01/2016
3	130-nm albumin-bound paclitaxelIBA 07/2018 - 01/2016
3	Carboplatin (JM8)FDA LinkGeneric 07/2018 - 01/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 01/2022
2	nintedanibIBA 12/2022 - 01/2018
2	Etoposide (VP 16)FDA LinkGeneric 12/2018 - 07/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2018 - 01/2012
1	Antifibrotic AgentsIBA 12/2023
1	Connective Tissue Growth FactorIBA 12/2023
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022
1	B7-H1 AntigenIBA 02/2022
1	Ferritins (Ferritin)IBA 08/2021
1	dacomitinibIBA 01/2021
1	Phosphotransferases (Kinase)IBA 10/2020
1	RNA (Ribonucleic Acid)IBA 07/2020
1	DNA (Deoxyribonucleic Acid)IBA 07/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	osimertinibIBA 01/2020
1	Antinuclear AntibodiesIBA 01/2019
1	Circulating Tumor DNAIBA 01/2019
1	AntibodiesIBA 01/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2018
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 07/2018
1	NivolumabIBA 07/2018
1	Albumin-Bound Paclitaxel FDA Link 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	LigandsIBA 01/2018
1	trkB ReceptorIBA 01/2018
1	AfatinibIBA 09/2017
1	Cisplatin (Platino)FDA LinkGeneric 09/2017
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 09/2017
1	Aspartic Acid (Aspartate)FDA Link 09/2017
1	Protein Isoforms (Isoforms)IBA 09/2017
1	Alanine Transaminase (SGPT)IBA 09/2017
1	Pemetrexed (MTA)FDA Link 09/2017
1	alectinibIBA 10/2015
1	Anaplastic Lymphoma KinaseIBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2012

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 12/2022 - 01/2011
3	Therapeutics 05/2022 - 07/2018
2	Immunotherapy 05/2022 - 01/2021
1	Chemoradiotherapy 03/2024
1	Aftercare (After-Treatment) 01/2020
1	Ligation 09/2017